DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
8	ハンチントン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03575676 (ClinicalTrials.gov)	August 8, 2018	11/6/2018	Efficacy and Safety of SOM3355 in Huntington's Disease Chorea	Phase IIa, Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of SOM3355 in Huntington's Disease (HD) Patients With Chorea Movements.	Huntington's Chorea	Drug: SOM3355 100mg BID;Drug: SOM3355 200mg BID;Drug: Placebo BID	SOM Biotech SL	NULL	Completed	18 Years	N/A	All	32	Phase 2	Spain

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT03575676
(ClinicalTrials.gov)

August 8, 2018

11/6/2018

Efficacy and Safety of SOM3355 in Huntington's Disease Chorea

Phase IIa, Double-blind, Randomized, Placebo-controlled Study of the Efficacy and Safety of SOM3355 in Huntington's Disease (HD) Patients With Chorea Movements.

Huntington's Chorea

Drug: SOM3355 100mg BID;Drug: SOM3355 200mg BID;Drug: Placebo BID

SOM Biotech SL

NULL

Completed

18 Years

N/A

All

Phase 2

Spain